oral naltrexone
Sponsors
University of Pennsylvania, State University of New York - Upstate Medical University, New York State Psychiatric Institute, US Department of Veterans Affairs, Fred Hutchinson Cancer Center
Conditions
Alcohol DependenceAlcohol Use DisorderBipolar DisordersHIVHIV InfectionsHeroin DependenceOpiate DependenceOpioid Dependence
Phase 1
Phase 2
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
CompletedNCT00218426
Start: 2006-07-31End: 2010-11-04Updated: 2019-03-18
Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX
CompletedNCT01101815
Start: 2010-06-30End: 2016-12-31Updated: 2018-11-08
Medication Maintenance Therapy in Community Pharmacy Settings
NCT04139213
Start: 2019-07-25End: 2022-10-01Target: 250Updated: 2022-08-24
Phase 3
Phase 4
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
CompletedNCT00453804
Start: 2006-07-31End: 2007-06-30Target: 15Updated: 2008-03-18
Pilot Study of Depot NTX in Homeless Veterans
TerminatedNCT01155869
Start: 2010-08-31End: 2012-06-30Updated: 2014-07-17
Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
CompletedNCT01377168
Start: 2014-05-31End: 2017-06-30Updated: 2017-06-16
Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings
CompletedNCT02978417
Start: 2017-09-21End: 2019-06-30Updated: 2020-06-16
In Hospital IM Naltrexone: A Pilot Study
WithdrawnNCT05087771
Start: 2022-03-31End: 2023-06-30Updated: 2023-04-07